ClinicalTrials.gov
public full text
Public Domain
A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The blinded phase only will be described in this record. Participants were randomized in a 4:1 ratio to receive GWP42003-P or matching placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing#372697
- Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer#1096152
- Massenspektrometrische und immunchemische Analyse von Cannabinoiden in biologischen Matrizes zur Evaluation aktueller forensisch-toxikologischer Fragestellungen im verkehrsmedizinischen Kontext / Lisa Höfert#1145591
- Linezolid Dosing Strategies in Drug-Resistant TB#810954
- Drug-drug Interactions Between AZD4205 and Itraconazole/Carbamazepine#854075
Record · ID 842936
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive